• News Releases

Genoa Healthcare’s handling of the pandemic featured in Chain Drug Review

Jun 8th, 2021

Increase in Mental Illness & Substance Abuse during Pandemic

As rates of mental illness and substance use disorder rose during the COVID-19 pandemic, Genoa Healthcare stepped up to improve access to care and promote better health care outcomes. Genoa’s efforts to meet the needs of the behavioral health community during the pandemic were featured recently in Chain Drug Review magazine. You can read the full article here or view it in the Chain Drug Review April issue.

The article highlights the growing need for behavioral health services and access to care and explains how Genoa pharmacies adapted to meet the changing needs of clinic partners and consumers. Pharmacies increased delivery and curbside pickup services, made proactive check-in calls and integrated with telehealth providers to ensure consumers were able to stay on their medication plans.

In addition, Genoa pharmacies have partnered with states and counties to administer COVID-19 vaccines in their local communities, ensuring that chronically underserved individuals had access to immunization clinics.

Read the full article for more information.

Recent Posts


  • Blog Post
Partnering with ACT teams to make an even bigger impact

Genoa Healthcare® pharmacist Julie R. has seen firsthand the impact that severe and persistent mental illness can have on a person. For one of her consumers living with schizophrenia, the...

  • Blog Post
  • Webinar
For consumers living with Tardive Dyskinesia, Genoa Healthcare’s Clinical Assistance Program offers personalized support

Tardive Dyskinesia – a neurological disorder linked to prolonged use of antipsychotic medications – impacts over 600,000 individuals each year. Did you know that 50% of consumers taking TD medication...

  • Blog Post
A foundation to build on: 3 ways an engaged pharmacy partner helps you deliver whole-person health

A recent survey found that nearly 60% of behavioral health, primary care and complex care providers reported that their organization currently offered or had plans to begin offering integrated care...

  • Clinical Insights
  • Webinar
Understanding Tardive Dyskinesia: What you need to know

Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually. Wondering what this means for the people you serve? Genoa...